Kate Lyden, PhD is the Chief Science Officer for VivoSense, a science and analytics company that develops and validates digital clinical measures and provides end-to-end services for their delivery in regulated clinical trials. In this role, Kate leads a team of scientists dedicate to developing and delivering real-world digital measures that are trusted and valued by all stakeholders.
Kate has an extensive and diverse background in the development and implementation of wearable sensor methodologies across clinical, academic, and industry settings. Her research has focused on synchronizing continuous measures of real-world physical behavior with physiological signals and patient reported outcomes to build contextually rich datasets that inform patient focused drug development and clinical care.
In addition to her work at VivoSense, Kate maintains adjunct faculty positions at The University of Massachusetts and Colorado State University, has authored many scientific publications on the objective measurement of human behaviors, and is a frequent contributor on this topic in academic, industry, and clinical working groups.
